Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma

NCT00975039 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Early end of enrolment with regards to difficulty met to enrol patients .

Conditions

Cholangiocarcinoma

Interventions

DRUG: WST11

Sponsor

Steba Biotech S.A.